Patients with juvenile idiopathic arthritis treated with etanercept
| Patient | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | B | C | D | E | F | G | H | I | K | L | M | N | O | P | Q | R | S | T | U | V | W | |
| Current age | 5 | 7 | 7 | 9 | 9 | 9 | 10 | 11 | 12 | 13 | 13 | 14 | 14 | 14 | 16 | 17 | 17 | 18 | 19 | 19 | 21 | 32 |
| Age at onset | 3 | 1 | 6 | 7 | 5 | 3 | 6 | 10 | 2 | 10 | 12 | 4 | 4 | 13 | 5 | 5 | 15 | 9 | 2 | 5 | 16 | 14 |
| Duration* | 2 | 6 | 1 | 2 | 4 | 6 | 4 | 1 | 10 | 3 | 1 | 10 | 10 | 1 | 11 | 12 | 2 | 9 | 18 | 14 | 5 | 18 |
| Sex | F | F | F | F | F | M | M | F | F | F | F | M | F | F | F | F | F | F | F | F | F | F |
| Type† | S | s | p | p | p | s | p | p | s | p | p | s | s | s | p | p | p | p | p | p | p | p |
| ANA | − | − | + | + | + | − | − | + | − | − | − | − | − | − | + | + | + | + | − | − | + | + |
| RF | − | + | − | + | − | − | − | + | − | − | + | − | − | − | + | − | + | + | − | − | + | − |
| x Ray‡ | o | e | n | e | o | a | e | o | o | e | o | a | o | o | o | o | o | e | e | e | e | o |
| Steroids§ | + | − | − | + | − | − | − | − | − | − | − | − | + | − | − | − | − | + | − | − | + | − |
| Duration¶ | 8 | 25 | 12 | 8 | 6 | 23 | 18 | 7 | 23 | 21 | 4 | 4 | 24 | 14 | 25 | 17 | 24 | 26 | 4 | 25 | 26 | 25 |
| *Duration of disease (years). | ||||||||||||||||||||||
| †Type of onset: p = polyarticular; s = systemic onset, polyarticular course; S = systemic onset with residual systemic activity. | ||||||||||||||||||||||
| ‡Diagnostic imaging: o = osteopenia; e = erosions; a = avascular necrosis, n = normal. | ||||||||||||||||||||||
| §Current low dose corticosteroids. | ||||||||||||||||||||||
| ¶Duration of treatment with etanercept ( months). | ||||||||||||||||||||||
| ANA = Antinuclear antibodies; RF = rheumatoid factor. | ||||||||||||||||||||||